FACTOR CERTIFICATE LONG - ROCHE GS Share Price

Certificat

L10RHU

CH1195560870

Market Closed - Swiss Exchange 16:20:00 16/04/2024 BST
0.01 CHF -50.00% Intraday chart for FACTOR CERTIFICATE LONG - ROCHE GS
Current year-75.00%

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer UBS
L10RHU
ISINCH1195560870
Date issued 14/06/2022
Strike 205.5 CHF
Maturity Unlimited
Parity 2645.5 : 1
Emission price 5.14 CHF
Emission volume N/A
Settlement Barausgleich
Currency CHF

Technical Indicators

Highest since issue 8.39 CHF
Lowest since issue 0.01 CHF
Spread 0.01 CHF
Spread %50.00%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
231 CHF
Average target price
277.5 CHF
Spread / Average Target
+20.14%
Consensus
  1. Stock Market
  2. Certificates
  3. L10RHU Certificat